ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Mycology and epidemiology of paracoccidioidomycosis

Mycology and epidemiology of paracoccidioidomycosis
Literature review current through: Jan 2024.
This topic last updated: Mar 15, 2022.

INTRODUCTION — Paracoccidioidomycosis is a systemic endemic mycotic disease caused by thermally dimorphic fungi of the genus Paracoccidioides, encompassing Paracoccidioides brasiliensis complex and Paracoccidioides lutzii. The fungus has a geographic distribution limited to Mexico and Central and South America, with the largest number of cases reported in Brazil, Argentina, and Colombia.

Basic aspects of the fungal pathogen and the epidemiology of paracoccidioidomycosis will be reviewed here. Clinical manifestations, diagnosis, and treatment of paracoccidioidomycosis are discussed separately. (See "Clinical manifestations and diagnosis of chronic paracoccidioidomycosis" and "Clinical manifestations and diagnosis of acute/subacute paracoccidioidomycosis" and "Treatment of paracoccidioidomycosis".)

MYCOLOGY — P. brasiliensis complex and P. lutzii are thermally dimorphic fungi that are found as a mycelium at 22 to 26°C and as a yeast at 37°C. This species lack a sexual stage (teleomorph).

In its mycelial form, Paracoccidioides species appear as thin septated hyphae with occasional chlamydospores and conidia [1]. In the yeast form, Paracoccidioides species are characterized by oval or round budding yeast cells of varying sizes (4 to 40 microns). The typical appearance is that of a large mother cell surrounded by multiple budding daughter cells (blastoconidia), often called a "pilot's wheel" (picture 1). When the mother cell has only two budding cells, it may resemble a "Mickey mouse head." (See "Clinical manifestations and diagnosis of chronic paracoccidioidomycosis", section on 'Microscopy'.).

The use of molecular tools has differentiated P. brasiliensis from P. lutzii, and has identified many cryptic species of P. brasiliensis: P. brasiliensis sensu stricto (variants S1a and S1b), which has been isolated in Brazil, Argentina, Paraguay, Peru, and Venezuela; P. americana (also known as PS2), present in Brazil, Venezuela, Uruguay, and Argentina; P. restrepiensis (also known as PS3), mainly present in Colombia; P. venezuelensis (also known as PS4), exclusively found in Venezuela [2,3]. P. lutzii occurs predominantly in the western-central region of Brazil and less so in southern and northern Brazil and Ecuador [4]. The clinical impact of this genotypic diversity is low. In a study comparing 51 patients infected by P. brasiliensis complex and 16 patients infected by P. lutzii, there were no observed differences in the epidemiology, clinical manifestations, and therapeutic response between the two groups [5]. However, patients infected with P. lutzii may be negative for the immunodiffusion test that detects antibodies against the gp43 antigen [6]. (See "Clinical manifestations and diagnosis of chronic paracoccidioidomycosis", section on 'Serologic tests'.)

EPIDEMIOLOGY — Based on epidemiologic surveys that employed intradermal tests for paracoccidioidin, the prevalence of Paracoccidioides infection in endemic areas may be as high as 50 to 75 percent among the adult population, and almost 10 million people may have been infected by this pathogen [7].

Active paracoccidioidomycosis is estimated to develop in 2 percent of infected individuals [7]. An epidemiologic study in a city in Brazil where paracoccidioidomycosis is hyperendemic reported a mean incidence of 2.7 cases per 100,000 inhabitants per year, with a stable incidence between 1960 and 1999 [8]. However, a subsequent study reported an incidence ranging from 9.4 to 40 cases per 100,000 inhabitants per year in a hyperendemic area in the state of Rondonia, West Amazon [9]. In Colombia, simulations of the incidence of paracoccidioidomycosis based on published series suggest that the six cities with the highest endemicity may have rates of 0.8 to 3.1 cases per 100,000 inhabitants per year [10].

Due to human migration and disturbances of soil during hydroelectric plant construction, highway building, deforestation, and expansion of agricultural frontiers, new hyperendemic areas have been documented in the eastern Brazilian Amazon region (states of Tocantins, Pará, and Maranhão), the westernmost part of the Brazilian Amazon region (state of Rondonia) and in some regions of Argentina and Paraguay [2,11].

Geography — Paracoccidioides species have a geographic distribution primarily limited to certain regions of Mexico and Central and South America (figure 1). Approximately 80 percent of cases have been reported in Brazil, with Colombia, Venezuela, and Argentina having the next highest numbers of cases [12-14]. Infections with Paracoccidioides species have also been observed as far north as Mexico and as far south as Argentina [15,16]. However, paracoccidioidomycosis has not been observed in certain countries within these latitudes, such as Chile, Surinam, Guyana, Nicaragua, Belize, and most of the Caribbean islands [1].

About 60 cases of paracoccidioidomycosis were reported in European countries, the United States, Canada, Japan, Africa, and the Middle East, all of them affecting patients who had visited or lived in South America [14]. In a systematic literature review of 83 paracoccidioidomycosis cases diagnosed in 11 European countries, the majority of cases were diagnosed in Spain (35 cases) and Italy (15 cases), and the latency period (period from leaving the endemic area and the diagnosis) ranged from 5 days to 50 years [17].

In Brazil, the largest endemic area comprises the southeast, midwest, and southern areas of the country. However, in the 1990s, the disease spread to the eastern border of the Amazon River, and subsequently to the western Amazon region, with an incidence of 9.4 cases per 100,000 inhabitants [9,15]. In a study that analyzed records from 6732 hospitalizations due to paracoccidioidomycosis in Brazilian public hospitals from 1998 to 2006, paracoccidioidomycosis represented 4.3 hospitalizations per 1.0 million inhabitants [18]. Hospitalizations occurred in all 26 states, illustrating that the disease remains endemic in a broad area of Brazil.

Within endemic countries, paracoccidioidomycosis has only been recognized in regions with certain ecologic characteristics, such as the presence of tropical and/or subtropical forests, abundant rivers, mild temperatures, high rainfall, and coffee and/or tobacco crops [1,10,12,13]. As an example, in 1985, a cluster of 10 cases of acute paracoccidioidomycosis in Brazil was associated with an increase in precipitation and air humidity caused by the 1982 to 1983 El Niño Southern Oscillation in the preceding years [19]. Similarly, a cluster of six cases of acute paracoccidioidomycosis was reported between 2009 and 2010 in the northeast part of Argentina and was associated with an El Niño Southern Oscillation that occurred in 2009 and 2010 [20]. An outbreak of acute paracoccidioidomycosis was also reported after deforestation and massive earth removal during the construction of a highway in the State of Rio de Janeiro, Brazil [21].

Habitat — The location of Paracoccidioides species in nature had remained unclear for a long time because Paracoccidioides species have rarely been isolated from the environment, the disease has a long latency period, and no outbreaks had been reported. Using modern molecular tools, Paracoccidioides species has now been recovered from the soil and air of endemic areas [22] and from animals, particularly nine-banded armadillos (Dasypus novemcinctus) [23,24]. Paracoccidioides brasiliensis complex was recovered from roadkill Cerdocyon thous (canids) and Cuniculus paca (rodents) in an endemic area for paracoccidioidomycosis [25].

Occupational exposure — Several investigators have indicated that paracoccidioidomycosis is more prevalent among rural workers engaged in intensive agriculture [1,26]. Human disease has been attributed to exposure to the fungus' habitat (soil) through agricultural work, primarily through coffee, cotton, and tobacco farming [10]. However, this epidemiologic scenario may change as a result of the evolution of agricultural practices, since the use of pesticides and plant burning has become common practice [27]. The use of fire may significantly elevate the soil temperature making it inhospitable for Paracoccidioides species. Many agricultural fungicides are azole derivatives, which could lead to a reduction in Paracoccidioides species in the environment [27,28].

Sex distribution — One of the most peculiar aspects of paracoccidioidomycosis is its distribution by sex. In adults with the chronic form, paracoccidioidomycosis is most prevalent among males between the ages of 30 and 60 years. The average male to female ratio is 13:1 in Brazil but may it be as high as 70:1 in other South American countries [26]. Beta-estradiol seems to protect adult females from developing the disease but not from infection. Of note, the high male to female ratio is not observed in prepubescent individuals who may present with the acute/subacute (juvenile) form of disease [7]. (See "Clinical manifestations and diagnosis of acute/subacute paracoccidioidomycosis".)

PATHOGENESIS — The main portal of entry for Paracoccidioides species is via inhalation into the lungs. Following acquisition, neutrophils and activated macrophages will block fungal growth and prevent dissemination of infection in most individuals. A type 2 (Th2) T helper cell response has been linked to susceptibility to disease, whereas a Th1 response has been associated with control of infection [29-32].

Patients exposed to Paracoccidioides species will form granulomas at the sites of primary infection and sometimes at metastatic foci, which may contain viable but quiescent forms of the fungus. After a long period of time (years), following loss of immune balance due to conditions not clearly defined, the infection may progress and give rise to full-blown disease (chronic form of paracoccidioidomycosis). Less frequently, systemic disease may progress from the primary focus of infection without a latency period, with rapid clinical deterioration (acute or sub-acute paracoccidioidomycosis) [7].

Despite the fact that cell-mediated immunity plays a major role in the defenses against Paracoccidioides species, the disease has rarely been reported among patients with human immunodeficiency virus (HIV) or other diseases associated with T-cell mediated immunodeficiency, such as cancer or solid organ transplantation. (See "Clinical manifestations and diagnosis of chronic paracoccidioidomycosis", section on 'Immunocompromised hosts'.)

SUMMARY

Introduction − Paracoccidioidomycosis is a systemic endemic mycotic disease caused by the thermally dimorphic fungi of the genus Paracoccidioides, with two species: Paracoccidioides brasiliensis and Paracoccidioides lutzii. (See 'Introduction' above.)

Mycology − In its mycelial form, Paracoccidioides appears as thin septated hyphae with occasional chlamydospores and conidia. In its yeast form, Paracoccidioides is characterized by oval or round budding yeast cells of varying sizes. The typical appearance is that of a large mother cell surrounded by multiple budding daughter cells (blastoconidia), often called a "pilot's wheel." (See 'Mycology' above.).

Epidemiology − Paracoccidioidomycosis is observed as a natural infection mostly in humans, but sporadic infections have also been reported in wild and domestic animals, particularly in nine-banded armadillos. (See 'Epidemiology' above.)

Geography Paracoccidioides has a geographic distribution primarily limited to certain regions of Central and South America. Infection with Paracoccidioides has also been observed as far north as Mexico and as far south as Argentina. Due to human migration and disturbances of soil during hydroelectric plant construction, highway building, deforestation, and expansion of agricultural frontiers, new hyperendemic areas have been documented in Brazil, Argentina, and Paraguay. (See 'Geography' above.)

HabitatParacoccidioides has been recovered in the soil and air of endemic areas, and in some animals, especially armadillos and other wild and domestic animals living in hyperendemic areas. (See 'Habitat' above.)

Occupational exposure − Human disease has been attributed to exposure to the fungus in soil through agricultural work, primarily coffee, cotton, and tobacco farming. (See 'Occupational exposure' above.)

Sex distribution − In adults with the chronic form, paracoccidioidomycosis is most prevalent among men between the ages of 30 and 60 years. (See 'Sex distribution' above.)

Pathogenesis − The main portal of entry for Paracoccidioides is through inhalation into the lungs. (See 'Pathogenesis' above.)

  1. Restrepo A, Tobon AM, Agudelo CA. Paracoccidioidomycosis. In: Diagnosis and Treatment of Human Mycoses, 1st edition, Hospenthal, DR, Rinaldi, MG (Eds), Humana Press, Totowa, NJ 2008. p.331.
  2. Cocio TA, Nascimento E, von Zeska Kress MR, et al. Phylogenetic Species of Paracoccidioides spp. Isolated from Clinical and Environmental Samples in a Hyperendemic Area of Paracoccidioidomycosis in Southeastern Brazil. J Fungi (Basel) 2020; 6.
  3. Teixeira MM, Cattana ME, Matute DR, et al. Genomic diversity of the human pathogen Paracoccidioides across the South American continent. Fungal Genet Biol 2020; 140:103395.
  4. Theodoro RC, Teixeira Mde M, Felipe MS, et al. Genus paracoccidioides: Species recognition and biogeographic aspects. PLoS One 2012; 7:e37694.
  5. Pereira EF, Gegembauer G, Chang MR, et al. Comparison of clinico-epidemiological and radiological features in paracoccidioidomycosis patients regarding serological classification using antigens from Paracoccidioides brasiliensis complex and Paracoccidioides lutzii. PLoS Negl Trop Dis 2020; 14:e0008485.
  6. Batista J Jr, de Camargo ZP, Fernandes GF, et al. Is the geographical origin of a Paracoccidioides brasiliensis isolate important for antigen production for regional diagnosis of paracoccidioidomycosis? Mycoses 2010; 53:176.
  7. Travassos LR, Taborda CP, Colombo AL. Treatment options for paracoccidioidomycosis and new strategies investigated. Expert Rev Anti Infect Ther 2008; 6:251.
  8. Bellissimo-Rodrigues F, Machado AA, Martinez R. Paracoccidioidomycosis epidemiological features of a 1,000-cases series from a hyperendemic area on the southeast of Brazil. Am J Trop Med Hyg 2011; 85:546.
  9. Vieira Gde D, Alves Tda C, Lima SM, et al. Paracoccidioidomycosis in a western Brazilian Amazon State: clinical-epidemiologic profile and spatial distribution of the disease. Rev Soc Bras Med Trop 2014; 47:63.
  10. Calle D, Rosero DS, Orozco LC, et al. Paracoccidioidomycosis in Colombia: an ecological study. Epidemiol Infect 2001; 126:309.
  11. Queiroz-Telles FV, Peçanha Pietrobom PM, Rosa Júnior M, et al. New Insights on Pulmonary Paracoccidioidomycosis. Semin Respir Crit Care Med 2020; 41:53.
  12. Brummer E, Castaneda E, Restrepo A. Paracoccidioidomycosis: an update. Clin Microbiol Rev 1993; 6:89.
  13. Restrepo A. The ecology of Paracoccidioides brasiliensis: a puzzle still unsolved. Sabouraudia 1985; 23:323.
  14. Martinez R. New Trends in Paracoccidioidomycosis Epidemiology. J Fungi (Basel) 2017; 3.
  15. Martinez R. EPIDEMIOLOGY OF PARACOCCIDIOIDOMYCOSIS. Rev Inst Med Trop Sao Paulo 2015; 57 Suppl 19:11.
  16. Restrepo A, McEwen JG, Castañeda E. The habitat of Paracoccidioides brasiliensis: how far from solving the riddle? Med Mycol 2001; 39:233.
  17. Wagner G, Moertl D, Glechner A, et al. Paracoccidioidomycosis Diagnosed in Europe-A Systematic Literature Review. J Fungi (Basel) 2021; 7.
  18. Coutinho ZF, Wanke B, Travassos C, et al. Hospital morbidity due to paracoccidioidomycosis in Brazil (1998-2006). Trop Med Int Health 2015; 20:673.
  19. Barrozo LV, Benard G, Silva ME, et al. First description of a cluster of acute/subacute paracoccidioidomycosis cases and its association with a climatic anomaly. PLoS Negl Trop Dis 2010; 4:e643.
  20. Giusiano G, Aguirre C, Vratnica C, et al. Emergence of acute/subacute infant-juvenile paracoccidioidomycosis in Northeast Argentina: Effect of climatic and anthropogenic changes? Med Mycol 2019; 57:30.
  21. do Valle ACF, Marques de Macedo P, Almeida-Paes R, et al. Paracoccidioidomycosis after Highway Construction, Rio de Janeiro, Brazil. Emerg Infect Dis 2017; 23:1917.
  22. Arantes TD, Theodoro RC, Teixeira Mde M, et al. Environmental Mapping of Paracoccidioides spp. in Brazil Reveals New Clues into Genetic Diversity, Biogeography and Wild Host Association. PLoS Negl Trop Dis 2016; 10:e0004606.
  23. Silveira LH, Paes RC, Medeiros EV, et al. Occurrence of Antibodies to Paracoccidioides brasiliensis in dairy cattle from Mato Grosso do Sul, Brazil. Mycopathologia 2008; 165:367.
  24. Corte AC, Svoboda WK, Navarro IT, et al. Paracoccidioidomycosis in wild monkeys from Paraná State, Brazil. Mycopathologia 2007; 164:225.
  25. de Souza Scramignon-Costa B, Almeida-Silva F, Wanke B, et al. Molecular eco-epidemiology of Paracoccidioides brasiliensis in road-killed mammals reveals Cerdocyon thous and Cuniculus paca as new hosts harboring this fungal pathogen. PLoS One 2021; 16:e0256668.
  26. Blotta MH, Mamoni RL, Oliveira SJ, et al. Endemic regions of paracoccidioidomycosis in Brazil: a clinical and epidemiologic study of 584 cases in the southeast region. Am J Trop Med Hyg 1999; 61:390.
  27. Nucci M, Colombo AL, Queiroz-Telles F, et al. Paracoccidioidomycosis. Curr Fung Infect Rep 2009; 3:15.
  28. Queiroz-Telles, F. Influence of alternating coffee and sugar cane agriculture in the incidence of paracoccidioidomycosis in Brazil. Biomedica 2008; 28(Suppl 1):129.
  29. Mamoni RL, Blotta MH. Kinetics of cytokines and chemokines gene expression distinguishes Paracoccidioides brasiliensis infection from disease. Cytokine 2005; 32:20.
  30. Karhawi AS, Colombo AL, Salomão R. Production of IFN-gamma is impaired in patients with paracoccidioidomycosis during active disease and is restored after clinical remission. Med Mycol 2000; 38:225.
  31. Benard G, Romano CC, Cacere CR, et al. Imbalance of IL-2, IFN-gamma and IL-10 secretion in the immunosuppression associated with human paracoccidioidomycosis. Cytokine 2001; 13:248.
  32. Marques Mello L, Silva-Vergara ML, Rodrigues V Jr. Patients with active infection with Paracoccidioides brasiliensis present a Th2 immune response characterized by high Interleukin-4 and Interleukin-5 production. Hum Immunol 2002; 63:149.
Topic 2434 Version 21.0

References

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟